Immunoregulatory effect

Immunoregulatory effect refers to the modulation of the immune system's response, encompassing both the enhancement (immunostimulation) and suppression (immunosuppression) of immune activity (StatPearls, 2023). It is a physiological or pharmacological outcome rather than a specific molecular target like a receptor or enzyme. In therapeutic contexts, achieving an immunoregulatory effect is the primary goal for treating autoimmune diseases, allergies, and preventing organ transplant rejection (NIH, 2022). Because the term describes a broad biological process or a drug's functional result, it does not represent a discrete protein or gene product that can be targeted by a ligand (IUPHAR/BPS Guide to Pharmacology). Drugs such as monoclonal antibodies, calcineurin inhibitors, and corticosteroids are used to induce these effects by acting on specific, well-defined molecular targets within the immune signaling cascade. Consequently, while the term is used to describe the desired clinical result, it lacks the molecular specificity required for target-based drug discovery. Analysts should distinguish between this functional outcome and the underlying molecular entities, such as cytokines or checkpoints, that serve as the actual therapeutic targets (PubMed, 2021).

Other names

ImmunomodulationImmune regulationImmunoregulatory activity

Not applicable as this is a biological process or pharmacological effect, not a specific molecular target.